Research Article| Volume 30, ISSUE 2, P260-264, February 1999

Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication


      Background/Aims: An involvement of Helicobacter pylori in the development of hepatic encephalopathy in cirrhotic patients has been proposed, but data confirming such an association are lacking. This prospective study aimed to assess whether ammonia levels and indicators of subclinical portosystemic encephalopathy were influenced by H. pylori status in a series of 62 cirrhotic patients. The effects of H. pylori eradication on such parameters were also investigated.
      Methods: Fasting blood ammonia levels, mental state, number connection test, flapping tremor, and EEG tracings were recorded at baseline, and in H. pyloripositive patients (as diagnosed by rapid urease test and 14C-urea breath test) these parameters were reassessed 2 months following eradication therapy.
      Results: In this series of non-advanced cirrhotic patients, the prevalence of H. pylori infection was 52%. No significant differences were observed between H. pylori+ and H. pylori− cases with respect to fasting venous blood ammonia concentration (47±24 vs 43±22 μmol/l) or to the remaining parameters assessing portosystemic encephalopathy. In addition, H. pylori eradication failed to induce any significant variation in either fasting blood ammonia levels (from 45±23 to 48±26 μmol/l) or neurologic disturbances.
      Conclusion: These results indicate that H. pylori infection is not a major contributing factor to either fasting blood ammonia levels or parameters assessing subclinical portosystemic encephalopathy in patients with non-advanced liver cirrhosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • The Eurogast Study Group
        Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations.
        Gut. 1994; 34: 1672-1676
        • Marshall B
        • Warren J
        Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.
        Lancet. 1984; i: 1311-1315
        • Graham DY
        • Lew GM
        • Klein PD
        • Evans DG
        • Evans Jr, DJ
        • Saeed ZA
        • et al.
        Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
        Ann Intern Med. 1992; 116: 705-708
        • Bayerdörffer E
        • Neubauer A
        • Rudolph B
        • Thiede C
        • Lehn N
        • Eidt S
        • et al.
        Regression of primary gastric lymphoma of mucosaassociated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
        Lancet. 1995; 345: 1591-1594
        • Hansson LE
        • Nyren O
        • Hsing AW
        • Bergstrom R
        • Josefsson S
        • Chow WH
        • et al.
        The risk of stomach cancer in patients with gastric or duodenal ulcer disease.
        N Engl J Med. 1996; 335: 242-249
        • Whincup PH
        • Mendall MA
        • Perry IJ
        • Strachan DP
        • Walker M
        Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men.
        Heart. 1996; 75: 568-572
        • Dunn BE
        • Campbell GP
        • Pérez-Pérez GI
        • Blaser MJ
        Purification and characterization of urease from Helicobacter pylori.
        J Biol Chem. 1990; 265: 9464-9469
        • Gubbins GP
        • Moritz TE
        • Marsano LS
        • Talwalkar R
        • McClain CJ
        • Mendenhall CL
        • et al.
        Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited.
        Am J Gastroenterol. 1993; 11: 1906-1910
        • Attili AF
        • Rinaldi V
        • Caschera M
        • Cedola M
        Helicobacter pylori: a major determinant of serum ammonia levels in cirrhotic patients.
        Hepatology. 1994; 20 ([abstract]): 110A
        • Rössle M
        • Haag K
        • Ochs A
        • Deibert P
        • Siegerstetter V
        • Kist M
        Helicobacter pylori infection is not associated with an increased risk of hepatic encephalopathy.
        Hepatology. 1994; 20 ([abstract]): 111A
        • Ito S
        • Miyaji H
        • Azuma T
        • Li Y
        • Ito Y
        • Kato T
        • et al.
        Hyperammonemia and H. pylori.
        Lancet. 1995; 346 ([letter]): 124-125
        • Quero JC
        • Hartmann IJC
        • de Rooij F
        • Wilson JHP
        • Schalm SW
        Hyperammonemia and Helicobacter pylori.
        Lancet. 1995; 346 ([letter]): 713-714
        • Plevris JN
        • Morgenstern R
        • Hayes PC
        • Bouchier IAD
        Hyperammonemia in cirrhosis and Helicobacter pylori infection.
        Lancet. 1995; 346 ([letter]): 1104
        • Dasani BM
        • Sigal SH
        • Lieber CS
        Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.
        Am J Gastroenterol. 1998; 93: 726-731
        • Rinaldi V
        • Zullo A
        • Diana F
        • Capocaccia L
        Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation?.
        Am J Gastroenterol. 1997; 92: 723-724
        • Miyaji H
        • Azuma T
        • Ito Y
        • Yamazaki Y
        • Ohtaki Y
        • Sato F
        • et al.
        Effects of H. pylori eradication therapy on hyperammonemia in patients with liver cirrhosis.
        Gut. 1997; 40: 726-730
        • Doi M
        • Takasu K
        • Samori T
        Blood chemical analysis. Effects of sample collection and subsequent processing on the test results: determination of blood ammonia level by direct deproteinization colorimetry.
        Rinsho Byori (Japan). 1996; 103: 156-161
        • Laine L
        • Lewin D
        • Naritoku W
        • Estrada R
        • Cohen H
        Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori.
        Gastrointest Endosc. 1996; 44: 523-526
        • Quero JC
        • Hartmann IJC
        • Meulstee J
        • Hop WCJ
        • Schalm SW
        The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
        Hepatology. 1996; 24: 556-560
        • Van der Rijt CCD
        • Schalm SW
        • de Groot GH
        • de Vlieger M
        Objective measurement of hepatic encephalopathy by means of automated EEG analysis.
        Electroencephalogr Clin Neurophysiol. 1984; 57: 423-426
        • Peura DA
        • Pambianco DJ
        • Dye KR
        • Lind C
        • Frierson HF
        • Hoffman SR
        • et al.
        Microdose 14C urea breath test offers diagnosis of Helicobacter pylori in 10 minutes.
        Am J Gastroenterol. 1996; 91: 233-238
        • Conn HO
        Assessment of the severity of hepatic encephalopathy.
        in: Rodés J Arroyo V Therapy in Liver Diseases. Doyma, Barcelona1992: 277-291
        • Jalan R
        • Seery J
        • Taylor-Robinson SD
        Pathogenesis and treatment of hepatic encephalopathy.
        Aliment Pharmacol Ther. 1996; 10: 681-697
        • Jones EA
        • Yurdaydin C
        • Basile As
        The GABA hypothesis-state of the art.
        Adv Exp Biol Med. 1994; 43: 27-71
        • Puxeddu A
        • Quartini M
        • Massimetti A
        • Ferrieri A
        Rifaximin in the treatment of chronic hepatic encephalopathy.
        Curr Med Res Opin. 1995; 13: 274-281
        • Morgan MY
        • Alonso M
        • Stanger LC
        Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
        J Hepatol. 1989; 8: 208-217
        • Kircheis G
        • Nilius R
        • Held C
        • Berndt H
        • Buchner M
        • Görtelmeyer R
        • et al.
        Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
        Hepatology. 1997; 25: 1351-1360
        • Rudman D
        • Di Fulco TJ
        • Galambos JT
        Maximal rates of urea synthesis in normal and cirrhotic subjects.
        J Clin Invest. 1973; 52: 2241-2246
        • Calvet X
        • Navarro M
        • Gil M
        • Mas P
        • Rivero E
        • Sanfeliu I
        • et al.
        Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis.
        J Hepatol. 1997; 26: 1249-1254
        • Wiedmann B
        • Klauck S
        • Kircheis G
        • Günther I
        • Malfertheiner P
        The influence of the Helicobacter pylori infection on the ammonia levels and psychometric tests in cirrhotic patients.
        Gastroenterology. 1997; 112 ([abstract]): A1415
        • Snady H
        • Lieber CS
        Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.
        Am J Gastroenterol. 1998; 83: 249-255
        • Salerno F
        • Moser P
        • Maggi A
        • Vitaliani G
        • Benetti G
        Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.
        J Hepatol. 1994; 21: 1092-1096
        • Rikkers J
        • Jenko P
        • Rudman D
        • Freides D
        Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.
        Gastroenterology. 1978; 75: 462-469
        • Mendenhall CL
        • Roselle GA
        • Grossman CJ
        • Rouster SD
        • Weesner RE
        False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis.
        N Engl J Med. 1986; 314: 921-922